No evidence of splenic disease in patients with splenic marginal zone lymphoma undergoing splenectomy for autoimmune hemolytic anemia after monotherapy with rituximab

Christina KalpadakisDepartment of Haematology, Heraklion University Hospital, University of Crete, Crete, Greece; Correspondence[email protected]

Gerassimos A. PangalisDepartment of Haematology, Athens Medical Center-Psychikon Branch, Athens, Greece;

Sotirios SachanasDepartment of Haematology, Athens Medical Center-Psychikon Branch, Athens, Greece;

Demetra RontogianniDepartment of Anatomic Pathology, Evangelismos General Hospital, Athens, Greece;

Penelope KorkolopoulouDepartment of Pathology, University of Athens, Athens, Greece;

Vassilis MilionisDepartment of Pathology, University of Athens, Athens, Greece;

Theodoros P. VassilakopoulosDepartment of Haematology, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece

Helen A. PapadakiDepartment of Haematology, Heraklion University Hospital, University of Crete, Crete, Greece;

Maria K. AngelopoulouDepartment of Haematology, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece

Your download is now in progress and you may close this window